Tag: Encorafenib
Nanoform outlicenses nanoencatafenib and signs development and commercialisation agreement
Nanoform Finland Plc (“Nanoform”), the medicine performance-enhancing company, announced that it has established, in collaboration with A.forall Development NV, a wholly owned subsidiary of...